Systemic CBD-IL-12 therapy was shown to remodel the tumor microenvironments of immunologically “cold” murine breast cancer and melanoma models through enhanced IFN-γ signaling and to cooperate with anti-PD-1 immune checkpoint inhibition to induce tumor eradication65. The gene discussed is IFNG; the disease is melanoma.